Name
Purdue University Globle
NU553 Advanced Pharmacology and Pharmacotherapeutics
Prof. Name
Date
Preparing for the NU553 Unit 4 Exam requires more than memorizing medication names. The most effective approach is to understand disease presentations, first-line pharmacologic treatments, mechanisms of action, adverse effects, contraindications, and patient counseling. This comprehensive NU553 Unit 4 study guide covers high-yield topics in neurological, psychiatric, gastrointestinal, endocrine, and substance use disorder pharmacology to help nursing students strengthen clinical reasoning and prepare for exam-style questions.
Headaches are common neurological complaints, but their causes and treatment strategies vary. For the NU553 Unit 4 exam, focus on distinguishing migraine, tension-type headache, cluster headache, and medication-overuse headache. Recognizing the clinical pattern helps guide treatment selection and identify patients who need further evaluation.
Migraine often causes moderate to severe, frequently pulsating pain and may be associated with nausea, vomiting, and sensitivity to light or sound. Some patients experience an aura before the headache. Tension-type headaches are generally characterized by mild to moderate pressure or tightness, while cluster headaches cause severe, often unilateral pain around the eye and occur in recurrent attacks.
Medication-overuse headache may develop when acute headache medications are used too frequently. Patients who regularly take medications such as triptans, opioids, or combination analgesics should be assessed for medication overuse.
Acute migraine treatment may include NSAIDs, acetaminophen, or migraine-specific medications such as triptans. Preventive therapy is considered when headaches are frequent, disabling, or inadequately controlled with acute treatment.
Important medication classes to review include:
Beta-blockers, such as propranolol.
Antiseizure medications, such as topiramate and valproate.
CGRP-targeted therapies.
Selected antidepressants, including amitriptyline.
For each medication, understand its mechanism of action, indications, adverse effects, contraindications, and clinically important interactions. Patients should also receive counseling about medication overuse, trigger management, and adherence to preventive therapy.
Seizure management begins with accurate classification. Different seizure types respond to different medications, and selecting an inappropriate antiseizure drug may worsen certain conditions. Exam questions commonly test seizure recognition, medication selection, titration, and safety monitoring.
Review the distinguishing features of:
Focal seizures, which originate in a specific region of the brain.
Generalized tonic-clonic seizures.
Absence seizures.
Myoclonic seizures.
Focal seizures that progress to bilateral tonic-clonic seizures.
Students should understand how impaired awareness, motor activity, and seizure duration influence clinical assessment.
Common antiseizure medications include levetiracetam, lamotrigine, valproate, carbamazepine, ethosuximide, and other agents selected according to seizure type and patient characteristics.
High-yield pharmacology concepts include:
Mechanism of action and seizure-specific indications.
Serious adverse effects and boxed warnings.
Drug interactions and contraindications.
Pregnancy-related safety considerations.
Dose titration and therapeutic monitoring.
Many antiseizure medications require gradual dose escalation. Lamotrigine is particularly important because rapid titration increases the risk of serious cutaneous reactions, including Stevens-Johnson syndrome. Monotherapy is often preferred when it provides adequate seizure control, although combination therapy may be necessary.
is a progressive neurodegenerative disorder associated with memory loss, cognitive decline, and impaired daily functioning. Pharmacologic management focuses on symptom control, preserving function where possible, and supporting patient and caregiver safety.
Cholinesterase inhibitors, including donepezil, rivastigmine, and galantamine, are commonly used for symptomatic treatment of Alzheimer’s disease. These medications increase the availability of acetylcholine in the brain by inhibiting its breakdown.
Students should understand:
Mechanism of action.
Indications and disease severity.
Gastrointestinal adverse effects.
Bradycardia and other safety concerns.
Drug interactions and patient counseling.
Donepezil may cause nausea, vomiting, diarrhea, and appetite changes. Counseling should emphasize proper administration, monitoring for adverse effects, and communicating persistent or severe symptoms to the healthcare provider.
Memantine, an NMDA receptor antagonist, is generally used for moderate to severe Alzheimer’s disease. It may be prescribed alone or in combination with a cholinesterase inhibitor.
Behavioral and psychological symptoms require individualized assessment. Nonpharmacologic interventions and treatment of contributing factors should be prioritized. Antipsychotics may be considered in selected circumstances when symptoms are severe or dangerous, but they carry important risks.
Caregiver education, fall prevention, medication adherence, and environmental safety remain essential parts of treatment.
develops partly from the loss of dopamine-producing neurons, resulting in impaired movement and other neurological symptoms. Pharmacologic treatment aims to improve mobility, reduce disability, and manage motor and nonmotor complications.
Common motor symptoms include resting tremor, bradykinesia, rigidity, and postural instability. Patients may also experience constipation, sleep disturbances, depression, autonomic symptoms, and cognitive changes.
Carbidopa/levodopa is a key treatment for motor symptoms. Levodopa is converted to dopamine in the brain, while carbidopa reduces peripheral conversion and helps improve levodopa availability.
Other medication classes include dopamine agonists, MAO-B inhibitors, COMT inhibitors, and amantadine.
Review the following concepts:
Mechanism of action and clinical indications.
Relative effectiveness and adverse effects.
Dose titration and treatment initiation.
Wearing-off and other motor fluctuations.
Drug interactions and patient counseling.
The wearing-off phenomenon occurs when Parkinson’s symptoms return before the next scheduled levodopa dose. Treatment adjustments may include changes in dosing schedules or additional medications.
Patient education should emphasize adherence, fall prevention, monitoring for dyskinesias, and reporting new or worsening symptoms.
Major depressive disorder (MDD) is a psychiatric condition involving persistent depressive symptoms that affect daily functioning. Diagnosis requires assessment of symptom patterns, duration, severity, and functional impairment.
SSRIs and SNRIs are commonly used as first-line pharmacologic treatments for MDD. These medications influence neurotransmitter activity involved in mood regulation.
Examples include:
SSRIs: Sertraline, fluoxetine, escitalopram, and paroxetine.
SNRIs: Venlafaxine and duloxetine.
Students should understand the expected timeline for therapeutic response, common adverse effects, contraindications, and the importance of continuing treatment as prescribed.
Additional medications that may appear on the NU553 exam include bupropion, mirtazapine, tricyclic antidepressants, and MAOIs.
Bupropion is associated with a lower risk of sexual adverse effects than many serotonergic antidepressants but is contraindicated in certain patients, including those with seizure disorders or eating disorders. Mirtazapine may increase appetite and cause sedation.
Tricyclic antidepressants and MAOIs require careful attention to toxicity, drug interactions, and safety precautions.
Bipolar disorder involves episodes of mood disturbance that may include depression, mania, or hypomania. Accurate differentiation between Bipolar I and Bipolar II is important for diagnosis and treatment planning.
Bipolar I disorder is characterized by at least one manic episode, which may be preceded or followed by depressive episodes. Bipolar II disorder involves hypomanic episodes and major depressive episodes without a history of mania.
Mood stabilizers and selected atypical antipsychotics are important components of treatment. Common medications include lithium, valproate, lamotrigine, and several atypical antipsychotics.
Exam preparation should focus on:
Acute mania versus bipolar depression treatment.
Maintenance therapy.
Medication monitoring requirements.
Adverse effects and contraindications.
Risks of antidepressant-induced mania or hypomania.
Lamotrigine is an important option for bipolar depression and maintenance in appropriate patients, particularly when depressive episodes are a concern. It requires slow titration because of the risk of severe skin reactions.
Anxiety disorders include several conditions with overlapping symptoms. The NU553 Unit 4 exam may assess diagnosis, treatment selection, medication safety, and the risks associated with long-term sedative use.
Review generalized anxiety disorder, panic disorder, social anxiety disorder, obsessive-compulsive disorder, and post-traumatic stress disorder.
Each condition has specific diagnostic features, but SSRIs and SNRIs are frequently used in pharmacologic management.
SSRIs and SNRIs are commonly recommended first-line medications for several anxiety disorders. Clinical improvement may take several weeks, and treatment often continues after symptom improvement to reduce relapse risk.
Benzodiazepines may provide rapid symptom relief in selected circumstances but are associated with sedation, dependence, tolerance, falls, and withdrawal. They should be prescribed carefully, with attention to duration of therapy and tapering requirements.
Students should understand:
Indications and contraindications.
Dependence and misuse risks.
Interactions with alcohol and other sedatives.
Safe discontinuation and tapering.
Alternative treatment options.
Sleep disorders require assessment of the specific complaint before selecting medication. Treatment should address contributing medical, psychiatric, and behavioral factors.
Patients may report difficulty falling asleep, frequent nighttime awakening, early morning awakening, or nonrestorative sleep. Treatment selection depends on the type of insomnia and patient characteristics.
Medication classes to review include benzodiazepine receptor agonists, orexin receptor antagonists, melatonin receptor agonists, and selected sedating antidepressants.
Students should understand the risks of sedation, impaired coordination, falls, and next-day impairment.
Restless legs syndrome causes an uncomfortable urge to move the legs, often worsening during rest or at night. Treatment may involve identifying contributing factors, assessing iron status when appropriate, and selecting medication based on current clinical guidance.
Narcolepsy is characterized by excessive daytime sleepiness and may include cataplexy. Pharmacologic treatment can involve wake-promoting medications, stimulants, and sodium oxybate in selected patients.
Review mechanisms of action, adverse effects, contraindications, and monitoring requirements.
ADHD is commonly treated with stimulant or non-stimulant medications. Treatment selection depends on symptoms, age, comorbidities, adverse effects, and patient preferences.
Important medications include methylphenidate, amphetamine-based stimulants, atomoxetine, and selected alpha-2 adrenergic agonists.
For the exam, focus on:
Mechanisms of action.
Appetite suppression and sleep disturbances.
Cardiovascular precautions.
Blood pressure and heart rate monitoring.
Misuse and diversion risks.
Important drug interactions.
Patient counseling should emphasize correct administration, adherence, safe storage, and follow-up monitoring.
Substance use disorder treatment combines medication, behavioral support, counseling, and long-term follow-up. Medication selection depends on the substance involved, withdrawal risks, medical history, and treatment goals.
Common medications include naltrexone, acamprosate, and disulfiram.
Naltrexone reduces the rewarding effects of alcohol and requires careful assessment of opioid use and liver-related concerns. Acamprosate supports maintenance of abstinence and requires renal considerations. Disulfiram produces an adverse reaction when alcohol is consumed and is appropriate only for carefully selected patients who understand the risks.
Key medications include buprenorphine, methadone, and naltrexone.
Buprenorphine and methadone are opioid agonist therapies used in medication treatment for opioid use disorder. Naltrexone is an opioid antagonist and requires the patient to be free of opioids before initiation to avoid precipitated withdrawal.
Exam questions may focus on indications, withdrawal management, safety monitoring, overdose prevention, and medication interactions.
Gastrointestinal pharmacology requires identifying the underlying cause before selecting medication. Treatment should address symptoms while preventing complications such as dehydration, electrolyte imbalance, or medication toxicity.
Common causes include motion sickness, pregnancy-related nausea, chemotherapy, and postoperative nausea and vomiting.
Medication classes to review include antihistamines, dopamine antagonists, serotonin 5-HT3 receptor antagonists, and other antiemetic therapies.
Prochlorperazine blocks dopamine receptors and may cause extrapyramidal symptoms, sedation, and other adverse effects. Students should understand when it may be used and which patients require additional precautions.
Initial management of constipation generally includes adequate hydration, dietary fiber, and physical activity when appropriate.
Pharmacologic options include bulk-forming agents, osmotic laxatives, stimulant laxatives, stool softeners, and prescription therapies for chronic idiopathic constipation or opioid-induced constipation.
Review first-line treatment, medication mechanisms, adverse effects, contraindications, and treatment escalation.
Diarrhea management focuses on hydration, electrolyte replacement, and identifying the cause. Oral rehydration therapy is essential for preventing dehydration.
Antidiarrheal medications such as loperamide may be useful in selected cases, but antimotility agents should be avoided or used cautiously when there is suspected invasive infection, bloody diarrhea, or certain other red flags.
GERD and peptic ulcer disease require a combination of lifestyle changes, medication therapy, and treatment of underlying causes.
Patients may benefit from weight management when appropriate, smoking cessation, avoiding meals close to bedtime, elevating the head of the bed, and identifying individual dietary triggers.
Lifestyle recommendations should be individualized rather than applying unnecessary food restrictions to every patient.
Common medications include proton pump inhibitors, H2 receptor antagonists, antacids, and sucralfate.
PPIs reduce gastric acid secretion by inhibiting the gastric H+/K+ ATPase. H2 receptor antagonists reduce acid secretion through histamine H2 receptor blockade.
For the NU553 exam, review mechanisms, administration, adverse effects, contraindications, and important drug interactions.
infection may contribute to peptic ulcer disease and requires guideline-based eradication therapy.
Treatment typically involves a combination of acid suppression and antibiotics, with the regimen selected according to local resistance patterns, previous antibiotic exposure, allergies, and current recommendations.
Chronic liver disease can cause serious complications, including portal hypertension, ascites, hepatic encephalopathy, and spontaneous bacterial peritonitis. Treatment aims to prevent complications and improve patient outcomes.
Review primary prevention, acute management, and secondary prevention of variceal bleeding. Nonselective beta-blockers and endoscopic interventions may be used depending on the clinical situation.
Acute variceal hemorrhage requires urgent management and may include vasoactive medications, antibiotics, and endoscopic treatment.
Ascites management often includes sodium restriction, assessment of fluid status, and diuretic therapy when appropriate. Spironolactone, sometimes combined with furosemide, is a key medication regimen.
Monitor electrolytes, renal function, blood pressure, daily weight, and clinical response.
Lactulose is used to reduce the absorption of ammonia by promoting its elimination through the gastrointestinal tract. Rifaximin may be added for recurrent hepatic encephalopathy in appropriate patients.
Important counseling points include medication adherence, bowel movement monitoring, dehydration prevention, and recognition of worsening mental status.
Also review spontaneous bacterial peritonitis, antibiotic prophylaxis when indicated, and chronic hepatitis B treatment during pregnancy. Management should follow current clinical guidelines and specialist recommendations.
Diabetes management combines lifestyle modification, blood glucose monitoring, and individualized medication therapy. Treatment selection depends on glycemic control, cardiovascular and renal disease, weight goals, adverse effects, and patient preferences.
Important components include medical nutrition therapy, physical activity, weight management, smoking cessation, and patient education.
Lifestyle interventions support glycemic control and reduce the risk of complications. They should be individualized to the patient’s health status and treatment goals.
The dawn phenomenon refers to elevated early morning blood glucose associated with normal hormonal changes during the early morning hours.
The Somogyi effect is a proposed rebound hyperglycemic response following overnight hypoglycemia. Students should understand how glucose monitoring helps distinguish these patterns.
Review the mechanisms and safety considerations for:
Metformin.
GLP-1 receptor agonists.
SGLT2 inhibitors.
DPP-4 inhibitors.
Sulfonylureas.
Thiazolidinediones.
Alpha-glucosidase inhibitors.
Bile acid sequestrants.
Insulin.
Inhaled insulin, such as Afrezza.
Metformin is commonly used as an initial medication when appropriate. GLP-1 receptor agonists and SGLT2 inhibitors may provide cardiovascular or renal benefits in selected patients, depending on the medication and individual risk profile.
Students should compare each class by mechanism of action, adverse effects, contraindications, drug interactions, and patient-specific benefits.
Insulin therapy requires careful attention to dosing, timing, glucose monitoring, and hypoglycemia prevention.
A commonly used starting approach for basal insulin in adults with type 2 diabetes is 10 units daily or 0.1–0.2 units/kg/day, followed by individualized titration based on fasting glucose and clinical response.
Patients should understand hypoglycemia symptoms, appropriate treatment, injection technique, medication storage, and the importance of consistent monitoring.
Endocrine pharmacology requires accurate interpretation of laboratory results and an understanding of how medications affect hormone production, replacement, and regulation.
Hypothyroidism is commonly associated with elevated TSH and low free T4 in primary disease. Levothyroxine is the standard thyroid hormone replacement medication.
Review:
Diagnostic laboratory patterns.
Dosing and administration.
Monitoring after dose changes.
Drug interactions.
Pregnancy considerations.
Levothyroxine is generally taken consistently on an empty stomach. Calcium and iron supplements can reduce absorption and should be separated according to clinical instructions.
Hyperthyroidism may present with suppressed TSH and elevated thyroid hormone levels. Treatment depends on the cause, disease severity, and patient factors.
Important medications and therapies include methimazole, propylthiouracil, beta-blockers, and radioactive iodine.
Methimazole is generally preferred in many nonpregnant adults, while propylthiouracil may be selected in specific situations, including certain pregnancy-related circumstances and thyroid storm.
Patients taking methimazole should be counseled to report fever or sore throat promptly because these symptoms may indicate agranulocytosis. Urgent evaluation and appropriate laboratory testing are required.
Review the clinical and pharmacologic management of hyperparathyroidism and hypoparathyroidism. Important concepts include calcium regulation, vitamin D therapy, calcium replacement, and monitoring of electrolyte levels.
These practice questions review common medication safety concepts and clinical scenarios. Use them to test your understanding, but confirm medication recommendations against your course materials and current guidelines.
A patient experiences 6–8 migraines each month despite appropriate acute treatment. Which medication is an evidence-supported option for migraine prevention?
Answer: Propranolol.
Propranolol is an established preventive medication for migraine. Treatment selection should consider contraindications, comorbidities, and patient-specific factors.
Why must lamotrigine be titrated slowly?
Answer: Rapid titration increases the risk of serious cutaneous reactions, including Stevens-Johnson syndrome.
Gradual dose escalation is important for reducing the risk of severe skin reactions. Patients should report concerning rash or mucosal symptoms immediately.
A patient taking donepezil develops nausea and vomiting. What counseling is appropriate?
Answer: Gastrointestinal adverse effects are common, but persistent or severe symptoms require evaluation.
Donepezil may cause nausea, vomiting, diarrhea, and appetite changes. Patients should follow prescribed instructions and report significant or worsening symptoms.
A patient with Parkinson’s disease reports that symptoms return before the next scheduled levodopa dose. What is this called?
Answer: Wearing-off effect.
Wearing-off occurs when the benefit of a medication dose declines before the next dose is due. Treatment adjustments may help manage motor fluctuations.
Which medication may be used for bipolar depression and maintenance treatment in selected patients while avoiding the routine use of antidepressant monotherapy?
Answer: Lamotrigine.
Lamotrigine is an important medication for bipolar depression and maintenance in appropriate patients. It requires slow titration and monitoring for serious skin reactions.
Which antiemetic blocks dopamine receptors and may cause extrapyramidal symptoms?
Answer: Prochlorperazine.
Prochlorperazine is a dopamine receptor antagonist. Extrapyramidal symptoms, sedation, and other adverse effects should be reviewed before administration.
Which medication is associated with weight loss and cardiovascular risk reduction in appropriate patients with type 2 diabetes?
Answer: Semaglutide.
Semaglutide is a GLP-1 receptor agonist that improves glycemic control and promotes weight loss. Cardiovascular benefit depends on the indication, formulation, and patient’s risk profile.
What is a commonly used starting dose for basal insulin in adults with type 2 diabetes?
Answer: 10 units daily or 0.1–0.2 units/kg/day.
The starting dose should be individualized. Fasting blood glucose monitoring and gradual titration help reduce the risk of hypoglycemia.
What is an important counseling point for levothyroxine?
Answer: Take it consistently on an empty stomach and separate it from calcium and iron supplements.
Food and mineral supplements can reduce levothyroxine absorption. Consistent administration and appropriate laboratory monitoring are essential.
A patient taking methimazole develops fever and sore throat. What should the patient do?
Answer: Seek immediate medical evaluation and follow instructions regarding the next dose.
Fever and sore throat may indicate agranulocytosis, a rare but potentially life-threatening adverse effect. Prompt evaluation and a complete blood count are important.
Understand headache classification, migraine prevention, and medication-overuse headache.
Learn seizure-specific medication selection and antiseizure drug safety.
Review cholinesterase inhibitors and memantine for Alzheimer’s disease.
Know carbidopa/levodopa, wearing-off, and other Parkinson’s medications.
Understand SSRIs, SNRIs, mood stabilizers, and atypical antipsychotics.
Review benzodiazepine dependence, withdrawal, and safe prescribing.
Master antiemetics, constipation medications, antidiarrheals, and acid-suppressing therapies.
Study liver disease complications, including ascites and hepatic encephalopathy.
Compare diabetes medication classes, cardiovascular benefits, and insulin titration.
Understand thyroid laboratory patterns, levothyroxine administration, and antithyroid drug safety.
The major topics include neurological disorders, psychiatric pharmacology, gastrointestinal conditions, liver disease, diabetes, thyroid disorders, sleep disorders, ADHD, and substance use disorders. Prioritize first-line medications, mechanisms of action, contraindications, adverse effects, and patient counseling.
High-yield classes include SSRIs, SNRIs, beta-blockers, antiseizure medications, GLP-1 receptor agonists, SGLT2 inhibitors, insulin, proton pump inhibitors, cholinesterase inhibitors, levodopa combinations, thyroid medications, and antithyroid drugs.
Understanding mechanisms of action helps explain therapeutic effects, predict adverse reactions, recognize drug interactions, and choose appropriate medications in patient case scenarios.
Use lecture notes, medication comparison charts, current clinical guidelines, and practice questions. Study by disease category and compare medications based on mechanism, indications, contraindications, adverse effects, and monitoring requirements.
Read each clinical scenario carefully. Identify the diagnosis, determine the treatment goal, assess relevant patient factors, and eliminate medications that are contraindicated or unsafe. Pay particular attention to boxed warnings, serious adverse effects, and patient counseling.
Effective NU553 Unit 4 exam preparation depends on connecting disease recognition with safe pharmacologic treatment. Instead of memorizing isolated medication names, focus on why a drug is selected, how it works, what adverse effects to monitor, and which patients require additional precautions. Combining disease-based study, evidence-based guidelines, and case-based practice can strengthen clinical reasoning and support success in advanced pharmacology exams.
American Diabetes Association Professional Practice Committee. (2025). Standards of care in diabetes—2025. Diabetes Care, 48(Supplement 1). https://diabetesjournals.org/care/issue/48/Supplement_1
American Psychiatric Association. (2023). The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia (3rd ed.). American Psychiatric Association Publishing. https://psychiatryonline.org
American Academy of Neurology. (n.d.). Clinical practice guidelines. https://www.aan.com/guidelines
American Association of Clinical Endocrinology. (n.d.). Clinical practice guidelines. https://pro.aace.com/clinical-guidance
Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (Eds.). (2023). Goodman & Gilman’s the pharmacological basis of therapeutics (14th ed.). McGraw Hill. https://accessmedicine.mhmedical.com
Joint Formulary Committee. (2025). British National Formulary (BNF). BMJ Group and Pharmaceutical Press. https://bnf.nice.org.uk
Katzung, B. G., & Trevor, A. J. (2024). Basic & clinical pharmacology (16th ed.). McGraw Hill. https://accessmedicine.mhmedical.com
National Institute for Health and Care Excellence. (n.d.). Guidance, standards and indicators. https://www.nice.org.uk/guidance
